|
Mitsubishi Tanabe to Buy Parkinson's Disease Drugs Firm NeuroDerm for $1.1B - Genetic
https://www.neurotalk.org//t1.gstati...nu0o9zAdRrhHxe
Endpoints News <img alt="" height="1" width="1"> Mitsubishi Tanabe to Buy Parkinson's Disease Drugs Firm NeuroDerm for $1.1B Genetic Engineering & Biotechnology News â??We believe that this transaction will yield important benefits for NeuroDerm's shareholders and the Parkinson's disease patients that urgently need new therapies,â?? stated Oded S. Lieberman, Ph.D., CEO of NeuroDerm. â??MTPC has demonstrated development ... Mitsubishi Tanabe bags NeuroDerm and its PhIII Parkinson's program for $1.1BEndpoints News Why NeuroDerm Ltd Acquired a Higher Price TodayMadison.com Mitsubishi Tanabe to buy Israel's NeuroDerm for $1.1 bnMedical Xpress The Jewish Press - JewishPress.com -The Times of Israel -BioPharma Dive all 32 news articles » More... |
| All times are GMT -5. The time now is 11:27 AM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.